We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+11.94%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.73B
AUM Growth
+$6.46M
Cap. Flow
-$42.8M
Cap. Flow %
-2.48%
Top 10 Hldgs %
30.81%
Holding
279
New
77
Increased
40
Reduced
47
Closed
83

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$14.4M
2
ILMN icon
Illumina
ILMN
+$11.2M
3
ICUI icon
ICU Medical
ICUI
+$10.4M
4
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
+$9.5M
5
OM icon
Outset Medical
OM
+$8.23M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$20.5M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$13.9M
3
LUNG icon
Pulmonx
LUNG
+$10.1M
4
NSTG
NanoString Technologies, Inc.
NSTG
+$9.8M
5
EVH icon
Evolent Health
EVH
+$7.06M

Sector Composition

Rank Sector Weight
1 Healthcare 34.81%
2 Industrials 0.32%
3 Materials 0.15%
4 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTLA icon
76
PUT
Intellia Therapeutics
NTLA
$1.69B
$5.61M 0.32%
100,300
-94,500
-49% -$5.86M
RGEN icon
77
PUT
Repligen
RGEN
$9.35B
$5.61M 0.32%
30,000
+5,000
+20% +$1.05M
CLDX icon
78
CALL
Celldex Therapeutics
CLDX
$3.52B
$5.53M 0.32%
196,600
-398,200
-67% -$12.2M
QTRX icon
79
CALL
Quanterix
QTRX
$139M
$5.51M 0.32%
+500,000
New +$6.36M
MIST icon
80
Milestone Pharmaceuticals
MIST
$141M
$5.48M 0.32%
596,531
-390,880
-40% -$2.96M
ZBH icon
81
CALL
Zimmer Biomet
ZBH
$18.7B
$5.23M 0.3%
+50,000
New +$5.49M
THC icon
82
Tenet Healthcare
THC
$21.5B
$5.16M 0.3%
+100,000
New +$5.93M
TMDX icon
83
Transmedics
TMDX
$3.02B
$5.01M 0.29%
+120,000
New +$5.22M
STE icon
84
PUT
Steris
STE
$23.1B
$4.99M 0.29%
+30,000
New +$6.1M
BCYC
85
Bicycle Therapeutics
BCYC
$284M
$4.96M 0.29%
213,121
+30,000
+16% +$714K
RCM
86
DELISTED
R1 RCM Inc. Common Stock
RCM
$4.83M 0.28%
260,400
+10,668
+4% +$243K
TNDM icon
87
CALL
Tandem Diabetes Care
TNDM
$1.63B
$4.79M 0.28%
+100,000
New +$5.48M
TSVT
88
DELISTED
2seventy bio
TSVT
$4.73M 0.27%
+325,000
New +$4.82M
COO icon
89
Cooper Companies
COO
$15B
$4.68M 0.27%
70,992
-59,008
-45% -$4.52M
PRVA icon
90
Privia Health
PRVA
$2.75B
$4.6M 0.27%
135,000
-43,255
-24% -$1.6M
DXCM icon
91
DexCom
DXCM
$34.3B
$4.57M 0.26%
+56,700
New +$4.8M
CUTR
92
CALL
DELISTED
Cutera, Inc.
CUTR
$4.56M 0.26%
100,000
+50,000
+100% +$2.28M
RCEL icon
93
Avita Medical
RCEL
$251M
$4.53M 0.26%
858,951
+117,076
+16% +$723K
TRUP icon
94
PUT
Trupanion
TRUP
$1.33B
$4.46M 0.26%
75,000
-34,000
-31% -$2.28M
TELA icon
95
TELA Bio
TELA
$32.3M
$4.43M 0.26%
520,079
-35,544
-6% -$295K
NTRA icon
96
CALL
Natera
NTRA
$45.5B
$4.38M 0.25%
+100,000
New +$4.76M
PFE icon
97
CALL
Pfizer
PFE
$150B
$4.38M 0.25%
+100,000
New +$4.86M
TERN
98
DELISTED
Terns Pharmaceuticals
TERN
$4.29M 0.25%
+728,600
New +$2.71M
MASI
99
CALL
DELISTED
Masimo
MASI
$4.24M 0.25%
+30,000
New +$4.38M
BVS icon
100
Bioventus
BVS
$1.17B
$4.11M 0.24%
586,696
-12,384
-2% -$97K
2 3
4
5 6

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2022 Portfolio in Review

As of Q3 2022, Pura Vida Investments held 279 positions worth $1.73B, up 0.38% from $1.72B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pura Vida Investments's Q3 2022 filing shows 77 new, 40 increased, 47 reduced and 83 closed positions. Its largest new stake was Illumina: 56,540 shares worth $10.5M. The largest sale was Biogen, an estimated $20.5M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Materials.

  • Pura Vida Investments's largest Q3 2022 buy was Illumina: 56,540 shares worth $10.5M.
  • Pura Vida Investments added most to United Therapeutics in Q3 2022, an estimated $14.4M increase.
  • Pura Vida Investments's biggest Q3 2022 reduction was Biogen, cutting an estimated $20.5M.
  • Pura Vida Investments fully exited Alnylam Pharmaceuticals in Q3 2022, selling an estimated $13.9M.
  • Pura Vida Investments's ten largest holdings make up 31% of its $1.73B portfolio in Q3 2022.
  • Pura Vida Investments opened 77 new positions and closed 83 in Q3 2022.
  • Pura Vida Investments's portfolio value rose 0.38% quarter-over-quarter to $1.73B.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.